Kuros Biosciences AG (KURN) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.53x

Kuros Biosciences AG (KURN) has a Cash Flow Reinvestment Rate of 0.53x as of December 2025, reinvesting CHF1.03 Million (capex CHF1.03 Million ) from operating cash flow of CHF1.94 Million. Check KURN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.53x

(Capex + Investments) / Operating CF

Total Reinvested

CHF1.03 Million

Capex + Investments

Operating Cash Flow

CHF1.94 Million

CHF

Capital Expenditures

CHF1.03 Million

CHF

Kuros Biosciences AG Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kuros Biosciences AG across 1 annual periods. Explore KURN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Kuros Biosciences AG (2024–2024)

Year-by-year capital reinvestment analysis for Kuros Biosciences AG. For live market cap and broader valuation context, see Kuros Biosciences AG stock valuation.

Year	Reinvestment Rate	Total Reinvested (CHF)	Operating CF	Capex	YoY Change
2024	0.71x	CHF2.22 Million	CHF3.14 Million	CHF1.11 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow